SightfileU.S. market data from official filings

QUIDELORTHO CORP (QDEL)

Name: QUIDELORTHO CORP (QDEL) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001906324 · EDGAR filings · Updated 2026-07-16

QUIDELORTHO CORP (QDEL) has reported institutional ownership of 120.5%, with 234 institutional managers holding positions valued at $1.35B per the latest 13F reporting period.

Institutional ownership

120.5%

Institutional managers

234

Reported 13F value

$1.35B

Insider activity

96 trans.

$1.22M net buying

Latest updates

2026-07-16 — Insider transaction reported (Form 4)
2026-07-15 — Initial insider ownership filed (Form 3)
2026-07-13 — Employee-plan registration (S-8) filed
2026-07-08 — SCHEDULE 13G filed
2026-07-02 — Insider transaction reported (Form 4)
2026-06-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, QUIDELORTHO CORP has 234 institutional holders and institutional ownership of 120.5%.

Insider activity

Insiders reported 96 transactions (9 buys, 1 sells) across 18 reporting insiders, with a net reported value of $1.22M.

Related companies

KALVISTA PHARMACEUTICALS INC (KALV) · PROGYNY INC (PGNY) · IMMUNITYBIO INC (IBRX) · HEALTHCARE SVCS GROUP INC (HCSG) · AVEANNA HEALTHCARE HLDGS INC (AVAH) · BAUSCH HEALTH COS INC (BHC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.